BIOD

Biodel Inc. News Headlines

$1.39
*  
0.03
2.21%
Get BIOD Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading BIOD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BIOD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Biodel Q1 Loss Narrows - Analyst Blog
2/10/2014 2:49:01 PM - Zacks.com


Avanir Reports Narrower Loss, Revs Up Y/Y - Analyst Blog
2/6/2014 12:40:01 PM - Zacks.com


ARIAD's Iclusig Returns to U.S. - Analyst Blog
1/21/2014 6:10:01 PM - Zacks.com


Some Stock Ideas For January 2014
1/8/2014 9:28:00 AM - Seeking Alpha


Sector Update: Healthcare Shares Flat Pre-Market; Biodel Up on Positive Coverage
1/3/2014 8:57:06 AM - MT Newswires


Sector Update: Healthcare
1/3/2014 8:54:58 AM - MT Newswires


Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014
1/2/2014 10:00:00 AM - Seeking Alpha


After-Hours Earnings Report for December 18, 2013 : ORCL, PAYX, MLHR, SCS, APOG, ARWR, BIOD
12/18/2013 2:00:03 PM - NASDAQ.com News


An Analysis Of Unilife's Products Shows A Weak Business Case
12/13/2013 9:01:00 AM - Seeking Alpha


Is Biodel A Buy Or Sell?
9/19/2013 4:40:00 PM - Seeking Alpha


Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
9/12/2013 10:55:00 AM - Seeking Alpha


Data on Biodel's BIOD-123 - Analyst Blog
9/10/2013 4:58:09 PM - Zacks.com


Wider-than-Expected Loss at Biodel - Analyst Blog
8/16/2013 8:25:58 AM - Zacks.com


Our BioPharma Catalyst Watch List
8/15/2013 8:30:00 AM - Seeking Alpha


Trade the Earnings: Biodel Inc.
8/12/2013 5:26:12 AM - MT Newswires


Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
8/5/2013 4:29:00 PM - Seeking Alpha


Why Biodel Will Have Positive Phase II Results
7/30/2013 10:05:00 AM - Seeking Alpha


3 Biotech Catalysts Primed To Be Successful In Q3
7/23/2013 2:08:00 PM - Seeking Alpha


Biodel Is A Vastly Undervalued Biotech With A Near-Term Catalyst
7/17/2013 1:13:00 PM - Seeking Alpha


Biodel: A Biotech Company Weathering The Volatility
6/26/2013 8:11:00 AM - Seeking Alpha


Market Wrap for Wednesday, June 19: Stocks Plunge as Federal Reserve Discusses Pulling Back Stimulus
6/19/2013 3:26:58 PM - Benzinga


Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
6/18/2013 8:01:00 AM - Seeking Alpha


Wednesday's Biotech Catalyst Trade Watch List
6/12/2013 8:00:00 AM - Seeking Alpha


This Under-The-Radar Diabetes Stock Has Significant Upside Potential
6/11/2013 9:29:00 AM - Seeking Alpha


Pivotal Progresses with Vascazen - Analyst Blog
4/16/2013 6:06:56 PM - Zacks.com